Response by Kuwabara et al to Letter Regarding Article, "Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized Controlled Trial"

Circulation. 2020 Feb 11;141(6):e67-e68. doi: 10.1161/CIRCULATIONAHA.120.045318. Epub 2020 Feb 10.

Authors

Masanari Kuwabara¹, Jun Sasaki², Tetsunori Saikawa³, Yasuyoshi Ouchi¹

Affiliations

¹ Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan (M.K., Y.O.).
² International University of Health and Welfare, Fukuoka, Japan (J.S.).
³ Okubo Hospital, Oita, Japan (T.S.).

PMID: 32078428
DOI: 10.1161/CIRCULATIONAHA.120.045318

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anticholesteremic Agents*
Atherosclerosis*
Cardiovascular Diseases*
Ezetimibe
Humans
Lipids

Substances

Anticholesteremic Agents
Lipids
Ezetimibe